Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
01 1CURIA FRANCE S.A.S. Bon-Encontre FR
01 1Hexetidine
01 1U.S.A
01 1Valid
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
Certificate Number : R1-CEP 2005-238 - Rev 03
Status : Valid
Issue Date : 2022-08-25
Type : Chemical
Substance Number : 1221
58
PharmaCompass offers a list of Hexetidine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Hexetidine manufacturer or Hexetidine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hexetidine manufacturer or Hexetidine supplier.
A Drossadin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Drossadin, including repackagers and relabelers. The FDA regulates Drossadin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Drossadin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Drossadin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Drossadin supplier is an individual or a company that provides Drossadin active pharmaceutical ingredient (API) or Drossadin finished formulations upon request. The Drossadin suppliers may include Drossadin API manufacturers, exporters, distributors and traders.
click here to find a list of Drossadin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Drossadin CEP of the European Pharmacopoeia monograph is often referred to as a Drossadin Certificate of Suitability (COS). The purpose of a Drossadin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Drossadin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Drossadin to their clients by showing that a Drossadin CEP has been issued for it. The manufacturer submits a Drossadin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Drossadin CEP holder for the record. Additionally, the data presented in the Drossadin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Drossadin DMF.
A Drossadin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Drossadin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Drossadin suppliers with CEP (COS) on PharmaCompass.
